Development and validation of an improved high-throughput method for the determination of anastrozole in human plasma by LC-MS/MS and atmospheric pressure chemical ionization

Journal of Pharmaceutical and Biomedical Analysis

Volumn 48, Issue 3, 2008, Pages 853-859

  Apostolou, Constantinos ^a   Dotsikas, Yannis ^a   Kousoulos, Constantinos ^a   Loukas, Yannis L ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

96 Well; Anastrozole; APCI; Bioequivalence; LC MS MS

Indexed keywords

ACETONITRILE; ANASTROZOLE; OMEPRAZOLE; TERT BUTYL METHYL ETHER;

ANALYTIC METHOD; AREA UNDER THE CURVE; ARTICLE; BIOEQUIVALENCE; DRUG BLOOD LEVEL; DRUG HALF LIFE; ELECTROSPRAY MASS SPECTROMETRY; HIGH THROUGHPUT SCREENING; HUMAN; HUMAN EXPERIMENT; HUMAN TISSUE; INTERMETHOD COMPARISON; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; MALE; MASS SPECTROMETRY; MAXIMUM PLASMA CONCENTRATION; NORMAL HUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

ACETONITRILES; AREA UNDER CURVE; AROMATASE INHIBITORS; ATMOSPHERIC PRESSURE; CHROMATOGRAPHY, LIQUID; HALF-LIFE; HUMANS; MALE; METHYL ETHERS; NITRILES; OMEPRAZOLE; REFERENCE STANDARDS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; SOLVENTS; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION; TABLETS; TANDEM MASS SPECTROMETRY; THERAPEUTIC EQUIVALENCY; TIME FACTORS; TRIAZOLES;

EID: 53249098414     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2008.06.006     Document Type: Article

References (24)

1. Plourde P.V., Dyroff M., and Dukes M. Breast Cancer Res. Treat. 30 (1994) 103-111
2. Grimm S.W., and Dyroff M.C. Drug Metab. Dispos. 25 (1997) 598-602
3. Lonning P.E. Breast Cancer Res. Treat. 49 (1998) S45-S52
4. Mauras N., O'Brien K.O., and Hayes V. J. Clin. Endocr. Metab. 85 (2000) 2370-2377
5. Mauras N., Lima J., Patel D., Rini A., di Salle E., Kwok A., and Lippe B. J. Clin. Endocr. Metab. 88 (2003) 5951-5956
6. Mendes G.D., Hamamoto D., Ilha J., Pereira A.S., and De Nucci G. J. Chromatogr. B 850 (2007) 553-559
7. Apostolou C., Kousoulos C., Dotsikas Y., Soumelas G.-S., Kolocouri F., Ziaka A., and Loukas Y.L. J. Pharm. Biomed. Anal. 46 (2008) 771-779
8. Liao K., Pack B.W., and Toltl N.P. J. Pharm. Biomed. Anal. 44 (2007) 118-126
9. Barrett B., Huclova J., Borek-Dohalsky V., Nemec B., and Jelinek I. J. Pharm. Biomed. Anal. 41 (2006) 517-526
10. Horning E.C., Horning M.G., Carroll D.I., Dzidic I., and Stillwell R.N. Anal. Chem. 45 (1973) 936-943
11. Kebarle P., and Peschke M. Anal. Chim. Acta 406 (2000) 11-35
12. In: Niessen W.M.A., and Cazes J. (Eds). Liquid Chromatography-Mass Spectrometry (1999), Marcel Dekker, Incorporation, New York
13. Cech N.B., and Enke C.G. Mass Spectrom. Rev. 20 (2002) 362-387
14. Ardrey R.E. Liquid Chromatography-Mass Spectrometry: An Introduction (2003), John Wiley & Sons
15. Constantopoulos T.L., Jackson G.S., and Enke C.G. J. Am. Soc. Mass Spectrom. 10 (1999) 625-634
16. Tang L., and Kebarle P. Anal. Chem. 63 (1991) 2709-2715
17. Enke C.G. Anal. Chem. 69 (1997) 4885-4893
18. Matuszewski B.K., Constanzer M.L., and Chavez-Eng C.M. Anal. Chem. 70 (1998) 882-889
19. Hsieh Y., Wang G., Wang Y., Chackalamannil S., Brisson J.M., Ng K., and Korfmacher W.A. Rapid Commun. Mass Spectrom. 16 (2002) 944-950
20. Dams R., Huestis M.A., Lambert W.E., and Murphy C.M. J. Am. Soc. Mass Spectrom. 14 (2003) 1290-1294
21. Mei H., Hsieh Y., Nardo C., Xu X., Wang S., Ng K., and Korfmacher W.A. Rapid Commun. Mass Spectrom. 17 (2003) 97-103
22. Apostolou C., Dotsikas Y., Kousoulos K., and Loukas Y.L. J. Chromatogr. B 848 (2007) 239-244
23. Annesley T.M. Clin. Chem. 49 (2003) 1041-1044
24. U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research (CDER), Center for Vetinary Medicine, 2001. Guidance For Industry. Bioanalytical method validation. http://www.fda.gov/cder/guidance/4252fnl.pdf.